The European Commission has granted a conditional marketing authorisation (CMA) for the COVID 19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU.
This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed by the Member States.
